Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T19:37:48.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message, replacing the study record content with an error page. This blocks access to the study details, contacts, and locations previously visible on the entry.
    Difference
    19%
    Check dated 2026-09-22T22:49:06.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.7.0, signaling a newer version of the page content. This update appears to be a backend/content version bump rather than a change to study details, eligibility, or results.
    Difference
    0.1%
    Check dated 2026-09-15T20:52:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Deleted the explicit disease label 'Multiple myeloma' and removed the related topics entries ('related topics:' and 'MedlinePlus Genetics'), reducing contextual disease tagging and external reference links on the study page.
    Difference
    0.2%
    Check dated 2026-09-08T19:44:18.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a newer version of the page.
    Difference
    0.1%
    Check dated 2026-09-01T18:17:40.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added the term Multiple myeloma, introduced a related topics header, and linked MedlinePlus Genetics as a related topic. This enhances disease-specific context and provides quick access to genetics-related information.
    Difference
    0.2%
    Check dated 2026-08-18T16:25:04.000Z thumbnail image

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.